Hematology/Oncology
RSSArticles
-
Troubled FluMist finds a silver lining
A novel influenza vaccine plagued by so much controversy the manufacturer almost gave up making it now is considered a good option for many health care workers during this seasons vaccine shortage, public health officials advise. -
Full November 2004 Issue in PDF
-
Pharmacology Watch: The FDA and Merck Fielding Concerns About Vioxx
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market. -
Prevention of Venous Thromboembolism in the Medical Patient: Fact vs. Fiction
Physicians increasingly are aware of the need to provide prophylaxis against venous thrombosis for the medically ill patient in the hospital environment. This article attempts to separate the fact from fiction regarding VTE prophylaxis. -
Full August issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: The Importance of Publishing Negative Clinical Studies
Cognitive Effects of Estrogen Therapy; Vitamin Therapy and Restenosis; Echinacea and the Common Cold; Effects of Paxil in Children Under 18; FDA Actions. -
Special Feature: Prevention of Ventilator-Associated Pneumonia
Ventilator-associated pneumonia (vap) is nosocomial pneumonia occurring in a mechanically ventilated patient > 48 hours after intubation. It is categorized as early-onset (defined by most experts as 48-96 hours after intubation) and late-onset (> 2-96 hours after intubation): these differ with respect to responsible bacterial agents as well as outcomes. With an estimated incidence of 8-28% of intensive care unit (ICU) patients, or 13-35 cases per 1000 ventilator-days, VAP is common. -
Steroids in Septic Shock: Which Patients? What Dose?
This meta-analysis of clinical trials of steroids in septic shock demonstrates that whereas short-term, high-dose administration actually worsens survival, giving lower doses for a longer period hastens shock resolution and improves survival. -
Full June issue in PDF